New York, November 02, 2016 -- Moody's Investors Service, ("Moody's") said j2 Global Inc.'s ("j2" or "the company") plan to acquire Everyday Health, Inc. ("EVDY") does not impact the company's B1 corporate family rating. EVDY operates a portfolio of healthcare focused digital assets as well as other healthcare marketing and communications solutions. The $465 million purchase is expected to be funded partially with incremental debt along with cash from the balance sheet. The debt component will be funded by drawing on a new revolving credit facility. This will result in only a modest increase to leverage and does not materially affect the company's credit metrics which remain strong for the B1 rating category. j2 will commence a tender offer to acquire all of the outstanding shares of Everyday Health in early November with the deal expected to close in the beginning of December. Following completion of the acquisition, EVDY would be a subsidiary of Ziff Davis, LLC., j2's digital media subsidiary.

Vollständigen Artikel bei Moodys lesen